Research Blogs

Read time: 5 minutes. Too often, lung cancer is found after it has already spread to other parts of the body, making treatment harder and lowering chances of curing the disease

Read time: 6 minutes. The American Association for Cancer Research (AACR) Annual Meeting brought together thousands of cancer researchers, clinicians, advocates, and patients in

Read time: 3 minutes. Clinical trials show us whether a new treatment is safe and effective. They are also an important way for patients to access cutting-edge care. For trials to

Read time: 4 minutes. Though many of us would like to deny it, our neighbors affect us. Their loud music disturbs our sleep. The scent of their dinner wafts through an open window

Read time: 3 minutes. The 2026 Targeted Therapies of Lung Cancer Meeting brought together leading clinicians, researchers, and patient advocates to discuss the latest advances

Read time: 3 minutes. Every January, the American Cancer Society releases a Cancer Facts & Figures report. It provides a clear view of where we stand in addressing cancer. The 2026

Read time: 3 minutes. Research funders are increasingly calling on researchers to move beyond studying communities to actively involving them in the research process. They want

Read time: 2 minutes. Artificial intelligence (AI) is rapidly reshaping the future of cancer care, but such dramatic innovation also brings important questions. AI has evolved from

Read time: 3 minutes. The human immune system is an intricate web of checks and balances that usually excels at detecting and destroying foreign invaders, such as bacteria and

Read time: 2 minutes. The Society for Immunotherapy of Cancer (SITC) celebrated their 40 th anniversary at their annual meeting in National Harbor, Maryland from November 5-9, 2025

LUNGevity partnered with MD Anderson, UT Southwestern, and UT San Antonio to host panel discussions sharing valuable insights and helpful resources for people living with lung

Read time: 1 minute. For more than two decades, LUNGevity Foundation has been a leader in advancing lung cancer research. Since 2002, we have invested $55+ million in more than 200